Literature DB >> 19204512

Small catheter tube thoracostomy: effective in managing chest trauma in stable patients.

Louis Rivera1, Eamon B O'Reilly, Michael J Sise, Valerie C Norton, C Beth Sise, Daniel I Sack, Sophia M Swanson, Rahwa B Iman, Gabrielle M Paci, Jared L Antevil.   

Abstract

BACKGROUND: Image-guided small catheter tube thoracostomy (SCTT) is not currently used as a first-line procedure in the management of patients with chest trauma. We adopted a practice recommendation to use SCTT as a less invasive alternative in the treatment of chest injuries. We reviewed our trauma registry to evaluate our change in practice and the effectiveness of SCTT.
METHODS: Retrospective review of all tube thoracostomies (TT) performed in patients with chest injury at a level I trauma center from September 2002 through March 2006. Data collected included age, sex, indications and timing for TT, use of antibiotics, length of stay, complications, and outcomes. Large catheter tube thoracostomy (LCTT) not performed in the operating room or trauma room and all SCTT were deemed nonemergent.
RESULTS: There were 565 TT performed in 359 patients. Emergent TT was performed in 252 (70%) and nonemergent TT in 157 (44%) patients, of which 63 (40%) received LCTT and 107 (68%) received SCTT. Although SCTT was performed later after injury than nonemergent LCTT (5.5 days vs. 2.3 days, p < 0.001), average duration of SCTT was shorter (5.5 days vs. 7 days, p < 0.05). Rates of hemothoraces were similarly low for SCTT versus nonemergent LCTT (6.1% vs. 4.2%, p = NS) and rates of residual/recurrent pneumothoraces were not significantly different (8% vs. 14%, p = NS). The rate of occurrence of fibrothorax, however, was significantly lower for SCTT compared with nonemergent LCTT (0% vs. 4.2%, p < 0.05). In patients receiving a single nonemergent TT, SCTT was performed in 55 (61%) and LCTT in 35 (39%). A comparison of these groups revealed that SCTT was performed in older patients (p < 0.05), and was associated with a lower Injury Severity Score (p < 0.05) and shorter length of stay (p = 0.05). SCTT was increasingly used in younger and more seriously injured patients as our experience grew.
CONCLUSION: SCTT is effective in managing chest trauma. It is comparable with LCTT in stable trauma patients. This study supports adopting image-guided small catheter techniques in the management of chest trauma in stable patients.

Entities:  

Mesh:

Year:  2009        PMID: 19204512     DOI: 10.1097/TA.0b013e318173f81e

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  5 in total

1.  Tube thoracostomy: a review for the interventional radiologist.

Authors:  Jeremy R Hogg; Michael Caccavale; Benjamin Gillen; Gavin McKenzie; Jay Vlaminck; Chad J Fleming; Andrew Stockland; Jeremy L Friese
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

Review 2.  Tube thoracostomy; chest tube implantation and follow up.

Authors:  Ivan Kuhajda; Konstantinos Zarogoulidis; Ioanna Kougioumtzi; Haidong Huang; Qiang Li; Georgios Dryllis; Ioannis Kioumis; Georgia Pitsiou; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Antonis Papaiwannou; Sofia Lampaki; Antonis Papaiwannou; Bojan Zaric; Perin Branislav; Konstantinos Porpodis; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 3.  A Primer on the Management of Pleural Effusions.

Authors:  William Bremer; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2019-02-05       Impact factor: 1.513

4.  Traumatic haemopneumothorax and 'whole-body' subcutaneous emphysema: successful use of a small-bore chest drain.

Authors:  Benjamin Hardy; Nicholas Sunderland; Mevan Perera; Kathryn Channing
Journal:  BMJ Case Rep       Date:  2016-12-02

5.  Comparing complications of small-bore chest tubes to large-bore chest tubes in the setting of delayed hemothorax: a retrospective multicenter cohort study.

Authors:  A Orlando; J Cordero; M M Carrick; A H Tanner; K Banton; R Vogel; M Lieser; D Acuna; D Bar-Or
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2020-06-22       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.